Vineet Laboratories Share Price

Vineet Laboratories Share Price

NSE: VINEETLAB
|
Pharmaceuticals

₹ 37.93

+₹0.63 (1.69%)
1D
Last updated 13 Oct, 2026, 15:59 IST

Vineet Laboratories Share Price Today

As of 14 Oct 2026, Vineet Laboratories share price is ₹37.93. The stock opened at ₹38.00, compared to its previous close of ₹37.30. During today's trading session, Vineet Laboratories share price moved in the range of ₹36.71 to ₹38.59, with an average price of ₹37.65 for the day. Looking at its last 52-week, the stock has touched a low of ₹27.96 and a high of ₹43.50. On the performance front, Vineet Laboratories share price has increased by 18.42% over the last six months and is down 9.99% on a year-on-year basis.

₹36.71
1.69% up today
₹38.59
1D LOW
1D HIGH

Vineet Laboratories Returns Calculator

Volume
1,19,171
Average traded price
₹37.92
Last traded time
03:59:28 13 Oct
Last traded quantity
19,475
Circuit
L
H
₹33.57
₹41.03
52-week
L
H
₹27.96
₹43.50
Mkt Cap Cr
72.77
P/E
64.64
P/B
1.58
ROA
0.89%
ROE
2.44%
ROCE
6.78%
EV/EBITDA
11.68
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Vineet Laborator outperforming all market indices
Step 1 of 5
Valuation
Overvalued
Vineet Laborator appears overvalued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEEV/EBITDA
Sun Pharmaceutical Industries4,22,067.0134.835.0511.19%13.74%17.33%21.42
Divis Laboratories2,48,982.9885.1214.8514.6%15.32%19.56%56.28
Torrent Pharmaceuticals1,76,300.5082.5521.164.87%25.49%13.85%38.11
Zydus Lifesciences1,13,615.6924.744.198.57%18.59%17.35%14.87
Laurus Labs1,11,898.66102.6321.1110.38%16.77%16.14%53.86
Cipla1,06,129.9631.623.087.92%11.27%14.95%17.83
Dr. Reddy's Laboratories1,02,707.4132.262.75.48%11.07%12.54%15.86
Mankind Pharma99,089.5247.926.087.36%11.74%13.13%25.7
Aurobindo Pharma97,972.4726.42.596.34%9.25%11.76%12.47
Lupin89,628.8316.033.9614.47%23.76%24.88%9.56

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

About Vineet Laboratories

Vineet Laboratories Share Price
ISIN
INE505Y01010
Sector Market Cap
₹ 72.77 Cr

Vineet Laboratories Limited is an India-based company engaged in the business of drug intermediates and bulk drugs. The Company specializes in pharmaceutical intermediates and fine chemicals. Its active pharmaceutical ingredient (API) intermediates products include Lopinavir, Ritonavir, Efavirenz, Nadolol, Glimepiride, Celecoxib, and Piroctone Olanine. Its fine chemicals and reagents include Isopropyl-beta-D-thiogalactopyranoside, 4-Nitrophenyl phosphate disodium salt, 5-Bromo-4-chloro-3-indolyl-beta-D-galactopyranoside (X-Gal), 5-Acetyl thiophene-2-carboxilic acid, n-Butyl Lithium, n-Butyl magnesium chloride, 3-Furaldehyde, 3-bromofuran, 1-methyl-imidazole-2-carboxaldehyde, 6-Aminouracil, Ethyldiazo acetate, and Phenylboronic acid. The Company also exports API intermediates, fine chemicals, and custom synthesis molecules.

Vineet Laboratories Financial Highlights

  • Revenue: Vineet Laboratories reported revenue of ₹59.50 crore in FY26 vs ₹76.99 crore in FY25. It showed a decrease of 22.72% on a yearly basis.
  • Operating Profit: Vineet Laboratories reported an operating profit of ₹1.28 crore in FY26 vs ₹20.78 crore in FY25. It showed an increase of 106.16% on a year-on-year basis.
  • Net Profit: Vineet Laboratories reported a net profit of ₹1.11 crore in FY26 vs ₹20.19 crore in FY25. It showed an increase of 105.50% on a yearly basis.

Vineet Laboratories Quarterly Result Highlights

  • Vineet Laboratories reported revenue of ₹18.92 crore in Mar 2026, compared with ₹15.70 crore in Dec 2025, representing an increase of 20.51% on a quarter-on-quarter (QoQ) basis.
  • Vineet Laboratories reported an operating profit of ₹0.99 crore in Mar 2026, compared with ₹0.82 crore in Dec 2025, representing an increase of 20.73% on a quarter-on-quarter (QoQ) basis.
  • Vineet Laboratories reported a profit of ₹0.73 crore in Mar 2026, compared with ₹0.85 crore in Dec 2025, reflecting a decrease of 14.12% on a QoQ basis.
  • The earnings per share (EPS) of Vineet Laboratories stood at ₹21.90 during Mar 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
5.98%
FII
0.50%
Other DII
0.00%
Retail and other
93.52%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20250.00%
Feb 20260.00%
Mar 20260.36%
Jun 20260.50%
1 day
+1.69%
1 week
+3.86%
1 month
+2.46%
1 year
-9.99%
3 years
-26.56%
5 years
-54.63%
Day
Open / Close
Change %
13 Oct 26
₹38.00 / ₹37.93
+1.69%
12 Oct 26
₹38.00 / ₹37.30
-0.40%
09 Oct 26
₹37.90 / ₹37.45
+2.60%
08 Oct 26
₹37.20 / ₹36.50
-0.41%
Show more

Vineet Laboratories Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹75.00₹150.59₹212.29₹191.17
Other Income₹1.99₹0.46₹0.12₹0.29
Total Revenue₹76.98₹151.05₹212.42₹191.46
Total Expenses₹97.76₹150.69₹210.39₹182.11
Profit Before Tax-₹20.78₹0.36₹2.03₹9.35
Tax-₹0.58-₹0.66₹0.78₹2.71
Profit After Tax-₹20.19₹1.03₹1.25₹6.64
EPS - Basic-₹21.90₹1.11₹1.36₹7.16
EPS - Diluted-₹21.90₹1.11₹1.36₹7.16

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax-₹20.78₹0.36₹2.03₹9.35
Income before WC changes-₹12.34₹7.15₹8.00₹13.25
Change in Assets₹21.13-₹1.21₹5.87-₹7.16
Change in Liabilities₹2.82-₹12.29-₹20.50₹4.72
Change in WC₹23.95-₹13.50-₹14.63-₹2.43
Cash flow from Operations₹11.49-₹6.61-₹9.62₹7.63
Cash flow from Investing-₹3.18-₹2.22-₹6.69-₹3.68
Cash flow from Financing-₹8.23₹8.43₹0.27₹11.96
Total Cash Flow₹0.08-₹0.40-₹16.03₹15.91
Cash (Start of the year)₹0.23₹0.63₹16.66₹0.75
Cash (End of the year)₹0.31₹0.23₹0.63₹16.66

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹27.15₹28.68₹28.39₹30.61
Current Assets₹67.39₹88.19₹87.46₹102.70
Total Assets₹94.54₹116.87₹115.85₹133.32
Current Liabilities₹74.39₹76.00₹74.51₹94.77
Net Current Asset-₹7.00₹12.19₹12.95₹7.94
Non-Current Liabilities₹5.50₹6.15₹7.66₹5.33
Equity Capital₹14.65₹34.72₹33.68₹33.22
Total Equity & Liabilities₹94.54₹116.87₹115.85₹133.32
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
37.93
525
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 525
Buy orders: 0%
Sell orders: 100%
Bearish
4
Neutral
3
Bullish
1
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
57.26
Neutral
ATR (14)
2.18
Neutral
STOCH(9,6)
83.42
Bearish
STOCH RSI (14)
100
Bearish
ADX(9)
24.77
Bearish
UO(9)
54.46
Neutral
ROC(12)
8.59
Bullish
WillR(14)
-14.7
Bearish
Period
Simple value
Exponential vaue
5D
37.17
37.31
10D
36.97
36.94
20D
36.21
36.72
50D
37.17
36.7
100D
36.18
36.19

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
Vineet Laboratories Share Price
Vineet Laboratories
Pharmaceuticals
Add Stock
Add Another

Vineet Laboratories Share Price FAQs

Disclaimer: The information on this page, including prices, charts, financials, ratios, and other data, is provided for informational and educational purposes only. It is not investment advice, a research report, or a recommendation or solicitation to buy, sell, or hold any security. Data is sourced from third parties and exchanges, may be delayed, and is not guaranteed to be accurate, complete, or timely. Upstox is not liable for any loss arising from its use.